E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/7/2014 in the Prospect News PIPE Daily.

Retrophin settles $45 million credit agreement through agent U.S. Bank

Offering also includes five-year warrants for 337,500 common shares

By Devika Patel

Knoxville, Tenn., July 7 – Retrophin, Inc. settled a $45 million credit agreement on June 30, according to an 8-K filed Monday with the Securities and Exchange Commission. U.S. Bank NA was the agent.

The credit agreement will be due on June 30, 2018 and accrues interest at a variable rate of Libor plus 1,000 basis points.

Investors also received warrants for 337,500 common shares, exercisable at $12.7552 for five years. The strike price is a 6.21% premium to the June 27 closing share price of $12.01.

The biopharmaceutical company is based in New York.

Issuer:Retrophin, Inc.
Issue:Credit agreement
Amount:$45 million
Maturity:June 30, 2018
Coupon:Libor plus 1,000 bps
Warrants:For 337,500 shares
Warrant expiration:Five years
Warrant strike price:$12.7552
Agent:U.S. Bank NA
Settlement date:June 30
Stock symbol:Nasdaq: RTRX
Stock price:$12.01 at close June 27
Market capitalization:$288.18 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.